skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: assunto: Humans remover Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation
Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using a Regimen of Fludarabine, Busulfan, and Total Lymphoid Irradiation

Abedin, Sameem ; Peres, Edward ; Levine, John E ; Choi, Sung ; Yanik, Gregory ; Couriel, Daniel R

Biology of blood and marrow transplantation, 2014-12, Vol.20 (12), p.2062-2066

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)

Advani, Anjali S. ; Gibson, Sarah ; Douglas, Elizabeth ; Diacovo, Julia ; Elson, Paul ; Kalaycio, Matt ; Copelan, Ed ; Sekeres, Mikkael ; Sobecks, Ronald ; Sungren, Shawnda ; Lagoo, Anand ; Rizzieri, David ; Hsi, Eric

British journal of haematology, 2011-05, Vol.153 (4), p.504-507 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse

Advani, Anjali S ; Shadman, Mazyar ; Ali-Osman, Francis ; Barker, Andrew ; Rybicki, Lisa ; Kalaycio, Matt ; Sekeres, Mikkael A ; de Castro, Carlos M ; Diehl, Louis F ; Moore, Joseph O ; Beaven, Anne ; Copelan, Ed ; Sobecks, Ronald ; Talea, Parisa ; Rizzieri, David A

Clinical lymphoma, myeloma and leukemia, 2010-12, Vol.10 (6), p.473-476 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia

Advani, Anjali S. ; Tse, William ; Li, Hong ; Jia, Xuefei ; Elson, Paul ; Cooper, Brenda ; Ali-Osman, Francis ; Park, Jino ; Rao, Arati V. ; Rizzieri, David A. ; Wang, Eunice S. ; Cotta, Claudiu V. ; Kalaycio, Matt ; Sobecks, Ronald M. ; Rouphail, Basel ; Maciejewski, Jaroslaw P. ; Fensterl, Jaime ; Carew, Jennifer S. ; Foster, Bethany ; Rush, Mary Lynn ; Tripp, Barbara ; Adams, Donna ; Corrigan, Donna ; Griffiths, Elizabeth A. ; Sekeres, Mikkael A.

Clinical lymphoma, myeloma and leukemia, 2021-02, Vol.21 (2), p.113-118 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma
Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma

Aggarwal, Sadhna ; Sharma, Suresh C. ; N.Das, Satya

Journal of surgical oncology, 2017-12, Vol.116 (8), p.1103-1113 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
High dose cytarabine, mitoxantrone and l -asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
High dose cytarabine, mitoxantrone and l -asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
Material Type:
Artigo 		Adicionar ao Meu Espaço

High dose cytarabine, mitoxantrone and l -asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly

Ahmed, Tamjeed ; Holwerda, Scott ; Klepin, Heidi D ; Isom, Scott ; Ellis, Leslie R ; Lyerly, Susan ; Manuel, Megan ; Dralle, Sarah ; Berenzon, Dmitriy ; Powell, Bayard L ; Pardee, Timothy S

Leukemia research, 2015-09, Vol.39 (9), p.945-949 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Increased BCR responsiveness in B cells from patients with chronic GVHD
Increased BCR responsiveness in B cells from patients with chronic GVHD
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increased BCR responsiveness in B cells from patients with chronic GVHD

Allen, Jessica L. ; Tata, Prasanthi V. ; Fore, Matthew S. ; Wooten, Jenna ; Rudra, Sharmistha ; Deal, Allison M. ; Sharf, Andrew ; Hoffert, Todd ; Roehrs, Philip A. ; Shea, Thomas C. ; Serody, Jonathan S. ; Richards, Kristy L. ; Jagasia, Madan ; Lee, Stephanie J. ; Rizzieri, David ; Horwitz, Mitchell E. ; Chao, Nelson J. ; Sarantopoulos, Stefanie

Blood, 2014-03, Vol.123 (13), p.2108-2115 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Quality of life and associated characteristics: application of WHOQOL-BREF in the context of Primary Health Care
Quality of life and associated characteristics: application of WHOQOL-BREF in the context of Primary Health Care
Material Type:
Artigo 		Adicionar ao Meu Espaço

Quality of life and associated characteristics: application of WHOQOL-BREF in the context of Primary Health Care

Almeida-Brasil, Celline Cardoso ; Silveira, Micheline Rosa ; Silva, Kátia Rodrigues ; Lima, Marina Guimarães ; Faria, Christina Danielli Coelho de Morais ; Cardoso, Claudia Lins ; Menzel, Hans-Joachim Karl ; Ceccato, Maria das Graças Braga

Ciência & saude coletiva, 2017-05, Vol.22 (5), p.1705-1716 [Periódico revisado por pares]

Brazil: Associacao Brasileira de Pos-Graduacao em Saude Coletiva - ABRASCO

Texto completo disponível

Citações Citado por
9
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

AMADORI, Sergio ; SUCIU, Stefan ; THOMAS, Xavier ; LATAGLIATA, Roberto ; HALKES, Constantijn J. M ; FALZETTI, Franca ; MAGRO, Domenico ; GUIMARAES, José E ; BERNEMAN, Zwi ; SPECCHIA, Giorgina ; KARRASCH, Matthias ; FAZI, Paola ; STASI, Roberto ; VIGNETTI, Marco ; WILLEMZE, Roel ; DE WITTE, Theo ; MARIE, Jean-Pierre ; SALIH, Helmut R ; SELLESLAG, Dominik ; MUUS, Petra ; DE FABRITIIS, Paolo ; VENDITTI, Adriano ; HO, Anthony D ; LÜBBERT, Michael

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4424-4430 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

Amato, Robert J. ; Jac, Jaroslaw ; Giessinger, Sarah ; Saxena, Somyata ; Willis, James P.

Cancer, 2009-06, Vol.115 (11), p.2438-2446 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (498)

Data de Publicação 

De até
Refinar
  1. Antes de2003  (14)
  2. 2003Até2007  (62)
  3. 2008Até2012  (164)
  4. 2013Até2018  (223)
  5. Após 2018  (79)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (540)
  2. Japonês  (80)
  3. Português  (3)
  4. Francês  (1)
  5. Espanhol  (1)
  6. Norueguês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.